2016

April 05, 2016
Patients with colorectal liver metastases gain wider access to unique benefits of yttrium-90 internal radiation therapy in the Netherlands

London, UK, 05 April 2016 Selective internal radiation therapy (SIRT), including TheraSphere®, reimbursed by Zorginstituut Nederland BTG plc (LSE: BTG), a global specialist healthcare company is...

April 05, 2016
BTG plc: Close Period Update

London, UK, 05 April 2016 BTG plc (LSE:BTG), the specialist healthcare company, provides the following update for the year ended 31 March 2016 ahead of the publication of its Final Results on 17...

April 02, 2016
BTG to initiate multi-centre TARGET study

London, UK, 02 April 2016 BTG to initiate multi-centre TARGET study evaluating dosimetry for 90Y radioembolisation therapy in patients with hepatocellular carcinoma BTG plc (LSE: BTG), a global...

April 01, 2016 BTG announces US launch of LC Bead LUMI™

London, UK, 01 April 2016 BTG announces US launch of LC Bead LUMI™, ground-breaking radiopaque embolic bead First and only, commercially available, radiopaque embolic bead in the US has...

March 10, 2016
BTG International Canada Expands Operations To Directly Sell Interventional Oncology Products

London, UK, 10 March 2016 DC Bead®, DC BeadM1® and Bead Block® Now Sold Directly to Specialist Physicians Across Canada BTG International Canada Inc., part of the international specialty...

Show 5102550100 per page
Top